News China National Essential Medicines List 2026: Key Updates on Innovative Drugs, GLP-1 and Cancer Therapies DengYueMed, DengYue 11/07/2026
News Eli Lilly’s Imlunestrant Approved in China: Oral SERD Offers a New Treatment Option for ESR1-Mutated Breast Cancer DengYueMed, DengYue 27/06/2026
News Silevimig Approved for Rabies Passive Immunization: The First Approved Bispecific Antibody for Rabies Prevention Worldwide DengYueMed, DengYue 26/06/2026
News China Approves the World’s First CAR-T Therapy for Solid Tumors: Satricabtagene Autoleucel for CLDN18.2-Positive Advanced Gastric Cancer DengYueMed, DengYue 24/06/2026
News Izalontamab Brengitecan Approved in China: World’s First EGFR×HER3 Bispecific ADC, a Breakthrough in Nasopharyngeal Cancer DengYueMed, DengYue 23/06/2026
News The World’s Second CFB Inhibitor Lanoracopan Approved by NMPA: China-Developed PNH Therapy Marks a Breakthrough DengYueMed, DengYue 16/06/2026
News Gumokimab Approved for Plaque Psoriasis in China: The IL-17A Therapy Landscape Continues to Evolve DengYueMed, DengYue 12/06/2026
News New Hemophilia Drug Approved in China: Bemiltenase Alfa Becomes World’s First Factor X Activator DengYueMed, DengYue 05/06/2026
News May 2026 China Innovative Drug Approvals: 5 Major New Drugs Approved DengYueMed, DengYue 03/06/2026
News Nipocalimab Approved in China for Generalized Myasthenia Gravis, With Long-Term Stable Disease Control Emerging as a Key Highlight DengYueMed, DengYue 27/05/2026
News Epcoritamab Approved in China for Follicular Lymphoma, Bringing a New CD20×CD3 Bispecific Therapy Option DengYueMed, DengYue 19/05/2026
News China Innovative Drug Approvals April 2026: 6 Approved, 5 by Chinese Companies DengYueMed, DengYue 07/05/2026